A class of drugs designed for diabetes management has become one of the most culturally charged medical phenomena of the decade, promising weight loss to millions while science struggles to keep pace with demand and mythology. GLP-1 medications like Ozempic do produce measurable results, but the full picture — who they help, who they harm, and what the body surrenders in the process — remains unresolved. As social media accelerates adoption and distorts guidance, the distance between clinical truth and cultural narrative has become a public health concern in its own right.